VIRX

Viracta Therapeutics, Inc. Common Stock
VIRX

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

VIRX was delisted on the 3rd of February, 2025.

Back to rankings

42 hedge funds and large institutions have $10.1M invested in Viracta Therapeutics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

more funds holding in top 10

Funds holding in top 10: →

28% less capital invested

Capital invested by funds: $14.1M → $10.1M (-$3.97M)

Holders
42
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$93.7K
2
+$29.4K
3
+$13.9K
4
XT
XTX Topco
Cayman Islands
+$12.6K
5
UBV
United Bank (Virginia)
Virginia
+$10.2K

Top Sellers

1
-$160K
2
-$72.1K
3
-$59K
4
BCM
Bridgeway Capital Management
Texas
-$53K
5
B
Bailard
California
-$37.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$7.8K
27
$5.26K
28
$3.85K
29
$3.12K
30
$3K
31
$1K
32
$1K
33
$750
34
$385
35
$208
36
$68
37
$15
38
$8
39
$5
40
$3
41
$2
42
–
43
–
44
–
45
–
46
–
47
–
48
–
1
2